SONER SOLMAZ, ZAFER GÖKGÖZ, ÇİĞDEM GEREKLİOĞLU, MAHMUT YERAL, CAN BOĞA, HAKAN ÖZDOĞU
Experimental and Clinical Transplantation - 2017;15(6):702-703
New-onset diabetes mellitus after solid-organ trans - plant makes for complicated tacrolimus immuno - suppression. However, tacrolimus-associated diabetic ketoacidosis has not been reported in bone marrow transplant. We report 24-year-old women, hos pitalized with diabetic ketoacidosis, 70 days after undergoing a bone marrow transplant with tacrolimus immunosup - pression. Clinicians should be wary about tacrolimus levels and the risk of hyperglycemic states after bone marrow transplant as with other solid-organ transplants.
